Taiwan FDA registration 522535a27e2221a7c9955cd0233dde8e

Baynex Respiratory Fusion Viral Antigen Rapid Diagnostic Test Card (Unsterilized)

TW: 拜奈克思呼吸道融合病毒抗原快速診斷檢驗卡 (未滅菌)

Taiwan·Risk Class 1·Abbott Diagnostics Scarborough, Inc.·Registered Jul 18, 2012 – Jul 18, 2027Active

Registration details

Analysis ID: 522535a27e2221a7c9955cd0233dde8e
Customs Code: DHA04401196302

Company information

Manufacturer: Abbott Diagnostics Scarborough, Inc.
Manufacturer Country: United States
Authorized Representative: Abbott Rapid Diagnostics Health Corp.

Product details

Intended Use: Limited to the classification and grading management of medical devices, the first level identification range of "respiratory fusion cell virus serum reagent (C.3480)".
Product Type (Level 1): C Immunology and microbiology
Product Type (Level 2): C.3480 呼吸道融合細胞病毒血清試劑
Import Information: import

Dates and status

Registration Date: Jul 18, 2012
Expiry Date: Jul 18, 2027

About this record

Access comprehensive regulatory information for Baynex Respiratory Fusion Viral Antigen Rapid Diagnostic Test Card (Unsterilized) in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 1 medical device is registered under number 522535a27e2221a7c9955cd0233dde8e and manufactured by Abbott Diagnostics Scarborough, Inc.. The authorized representative in Taiwan is Abbott Rapid Diagnostics Health Corp..

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.